Disc Medicine (IRON) news
Recent news
Disc Medicine - ends Q2 2026 with $717.70 mln in cash and securities; runway into 2029
AInvest Wire · Jul 30, 2026Disc Medicine - enters first amendment to loan agreement on June 25, 2026 - SEC filing
On June 25, 2026, Disc Medicine, Inc. (NASDAQ: IRON) executed the first amendment to its existing loan agreement, as disclosed in a recent SEC filing. The amendment outlines adjustments to the terms of the company’s debt obligations, reflecting ongoing efforts to align its financial structure with…
AInvest Wire · Jun 30, 2026Disc Medicine: Data from Apollo expected in Q4 2026, after which a CRL response will be submitted with an FDA decision expected by mid-2027
AInvest Wire · Jun 1, 2026Australia foreign minister: Suspended operations at embassy in Tehran due to deteriorating security environment in Iran
Australia foreign minister: Suspended operations at embassy in Tehran due to deteriorating security environment in Iran In response to the deteriorating security environment in Iran, the Australian government has decided to suspend operations at its embassy in Tehran. This move comes amidst…
AInvest Wire · Jun 19, 2025ECB's Simkus: Uncertainty leads in many cases to a more deflationary environment
ECB's Simkus: Uncertainty leads in many cases to a more deflationary environment As the global economy continues to navigate through a period of uncertainty, the European Central Bank (ECB) has highlighted the potential for deflationary pressures. ECB Executive Board member, Peter Praet, recently…
AInvest Wire · Apr 24, 2025Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.